As the Russian invasion of Ukraine enters its second week, efforts are being made across the European off-patent industry to secure the supply chain and maintain access to essential medicines for Ukraine’s 44 million citizens.
Concerns have been raised over the past week that medicine supplies are already dwindling
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?